ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HONA
6. TTWO
7. HELP
8. GDYN
9. NKE
10. MSCI

Go back to ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth

ANI Pharma (ANIP) Misses Q4 EPS by 14c, Revenue Beats

March 9, 2021 6:51 AM EST

ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.80, $0.14 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $57.3 million versus the consensus estimate of $54.27 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

... More